便携式房颤筛查设备在初级保健心血管筛查中的表现
研究在5天内对1518例转诊超声心动图的初级保健患者进行手持双电极房颤筛查设备(AFSD)检测,AFSD阳性率6.4%,与超声心动图发现心脏病独立相关(OR=3.9),相比12导联心电图检测房颤的敏感性90.2%、特异性84.0%。
要点
- AFSD在初级保健转诊超声患者中筛查房颤敏感性90.2%、特异性84.0%。
- AFSD阳性与超声心动图心脏病独立相关(OR=3.9,95%CI 2.1-7.2)。
- 高龄(>65岁)者AFSD阳性率更高(9.3% vs 4.8%,p=0.001)。
核心结论
- AFSD在转诊超声心动图的初级保健患者中检测房颤具有高敏感性。
- 房颤患病率较高且与结构或功能性心脏病独立相关,提示AFSD筛查可用于风险分层和优先安排超声。
研究设计与样本
- 前瞻性筛查研究,5天内纳入1518例初级保健转诊超声心动图患者,平均年龄58±16岁,66%女性。
- AFSD阳性者及250例AFSD阴性者接受12导联心电图;根据临床风险评分行超声心动图。
主要发现
- AFSD阳性率为6.4%,高风险组12.6%、中风险组6.1%、低风险组2.2%。
- 年龄>65岁者AFSD阳性率9.3%,≤65岁者4.8%(p=0.001)。
- AFSD阳性与超声心动图心脏病独立相关(OR=3.9,95%CI 2.1-7.2,p<0.001)。
- 对比12导联心电图,AFSD检测房颤的敏感性90.2%(95%CI 77.0%-97.3%),特异性84.0%(95%CI 79.3%-88.0%)。
临床怎么用
- 在初级保健中,对转诊超声心动图的患者可使用AFSD进行房颤筛查。
- AFSD阳性提示需优先安排超声心动图以评估结构或功能性心脏病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: A novel handheld dual-electrode stick is a portable atrial fibrillation (AF) screening device (AFSD). We evaluated AFSD performance in primary care patients referred for echocardiogram (echo). METHODS: The AFSD has a light indication of irregular rhythm and single-lead ECG recording. Patients were instructed to hold the device for 1 min, and AF indication was recorded. A 12-lead ECG was performed for all AFSD-positive patients and 250 patients with negative AFSD screen. Echos were performed based on a clinical risk score: all high-risk patients and a sampling of low-risk patients underwent complete echo. Intermediate risk patients first had a screening echocardiogram, with a follow-up complete study if abnormality was suspected. RESULTS: In 5 days, 1518 patients underwent clinical evaluation and cardiovascular risk stratification: mean age 58±16 years, 66% women. The AFSD was positive in 6.4%: 12.6% high risk, 6.1% intermediate risk and 2.2% low risk. Older age was a risk factor (9.3% vs 4.8% in those more than and less than 65 years, p=0.001). AFSD positive was independently associated with heart disease in echo (OR=3.9, 95% CI 2.1 to 7.2, p<0.001). Compared with 12-lead ECG, the AFSD had sensitivity of 90.2% (95% CI 77.0% to 97.3%) and specificity of 84.0% (95% CI 79.3% to 88.0%) for AF detection. CONCLUSION: AFSD demonstrated high sensitivity for AF detection in primary care patients referred for echo. AF prevalence was substantial and independently associated with structural or functional heart disease, suggesting that AFSD screening could be a useful primary care tool to stratify risk and prioritise echo.
引用
- Diamantino AC, Nascimento BR, Beaton AZ, et al. Atrial fibrillation detection with a portable device during cardiovascular screening in primary care. Heart. 2020. PMID: 32019822. doi:10.1136/heartjnl-2019-316277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。